Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 7/20 | 0.50 |
| ▸ | F10 | P00742 | 3/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.39 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.39 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.39 |
| ▸ | FGF1 | P05230 | 2/20 | 0.39 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.39 |
| ▸ | FGF2 | P09038 | 1/20 | 0.39 |
| ▸ | VEGFA | P15692 | 1/20 | 0.39 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.39 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.38 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15948436 | 0.90 | LGALS8 (0.47) | LGALS8F10FGF1FGF2VEGFA | |
| SCHEMBL18122122 | 0.90 | LGALS8 (0.49) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL19789921 | 0.89 | LGALS8 (0.41) | LGALS8F10LGALS3LGALS9LGALS1 | |
| SCHEMBL13867741 | 0.87 | LGALS3 (0.47) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL13560177 | 0.87 | LGALS3 (0.47) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL14255515 | 0.87 | LGALS3 (0.47) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL10014356 | 0.87 | LGALS8 (0.52) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL13559835 | 0.87 | LGALS3 (0.47) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL13560166 | 0.87 | LGALS3 (0.47) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL17087678 | 0.87 | LGALS8 (0.55) | LGALS8LGALS3LGALS9LGALS1LGALS7; LGALS7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10456353-B2 | Personal care compositions | CONOPCO, INC. (US) | 2019-10-29 | — | — | US | disclosed |
| US-10449143-B2 | Aloe vera extract for personal care compositions | CONOPCO, INC. (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3131529-B1 | ALOE VERA EXTRACT FOR PERSONAL CARE COMPOSITIONS | UNILEVER NV (NL) | 2018-01-24 | — | — | EP | disclosed |
| EP-3131564-B1 | PERSONAL CARE COMPOSITIONS | UNILEVER NV (NL) | 2017-12-20 | — | — | EP | disclosed |
| US-20170035686-A1 | PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10449143-B2 | Aloe vera extract for personal care compositions | CUTA, TELO2, HAAO | LGALS8 57/4885F10 717/4885LGALS3 47/4885 |
| US-20170035686-A1 | PERSONAL CARE COMPOSITIONS | CD44, KRT18, CUTA | LGALS8 241/4885F10 501/4885LGALS3 231/4885 |
| US-10456353-B2 | Personal care compositions | CD44, KRT18, CUTA | LGALS8 241/4885F10 501/4885LGALS3 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.